Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Invasive Transitional and Squamous Cell Carcinoma of the Bladder: Effect on Survival and Bladder Preservation
Authors:
- 1 October 2014
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 12 (5) , e233-e240
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Radical Cystectomy for Urothelial Carcinoma of the Bladder Without Neoadjuvant or Adjuvant Therapy: Long-Term Results in 1100 PatientsEuropean Urology, 2012
- Relative Efficacy of Perioperative Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Adriamycin, and Cisplatin in the Management of Locally Advanced Urothelial Carcinoma of the BladderUrology, 2012
- Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladderCancer, 2011
- Neoadjuvant cisplatin for advanced bladder cancerCochrane Database of Systematic Reviews, 2011
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 TrialJournal of Clinical Oncology, 2011
- Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient DataEuropean Urology, 2005
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trialThe Lancet, 1999
- Overview: Late effects of normal tissues (LENT) scoring systemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995